ClinicalTrials.Veeva

Menu

Interest of Relaxation From Patients With Pain Due to Migraine (MIGREL)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Migraine

Treatments

Behavioral: relaxation (Schultz)

Study type

Interventional

Funder types

Other

Identifiers

NCT00904527
0601001b

Details and patient eligibility

About

The purpose of this study is to determine whether relaxation (autogenic training of Schultz) is effective in treatment for migraine.

Full description

This randomized, multicenter study compares 2 parallel groups of patients with migraine :

  • I: patients are treated with relaxation + medical treatment (beta-bloquant or Oxetorone)+ patients' education
  • II: patients are treated only with medical treatment + patients' education.

Visit 1 : 1 month before randomization for patient's selection and baseline data

Visit 2 (J0): inclusion (randomization) During the first 2 months patients from group I benefit from relaxation consultations.

Visit 3 (2 months after randomization)and visit 4 (4 months after randomization) : evaluation of the efficacy of the two treatment strategies.

Primary endpoint :

  • number of days with migraine per month from J0 to visit 4.

Secondary endpoints :

  • monthly drug consumption
  • percentage of patients who respond (50 % frequency reduction)
  • quality of life (SF 36)

Each day, patients note in a notebook if a migraine appears and its intensity.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age > 18 years
  • 5 to 14 days of migraines per month

Exclusion criteria

  • Headache by medication abuse
  • Patients who already know relaxation technics
  • Depression
  • Contra indication of using beta-bloquant or Oxetorone

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Relaxation
Experimental group
Description:
Relaxation (Schultz)+ medical treatment (beta-bloquant or Oxetorone)+ patient's education
Treatment:
Behavioral: relaxation (Schultz)
without relaxation
No Intervention group
Description:
Patients have no relaxation (only medical treatment+ education)

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems